OlinOLN
OLN logo
Fair Value
US$35.83
Share price14 Jul
US$19.0646.8% undervalued intrinsic discount
Loading
1Y-11.72%
7D1.71%

Global Urbanization And Electrification Will Expand Specialty Chemicals Markets

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published
26 Apr 25
Updated
14 Jul 26
Views
84
Not Invested

Last Update 14 Jul 26

Fair value Decreased 5.60%

OLN: Huntsman Merger Will Reshape Earnings Mix And Support Post 2025 Recovery

Analysts have trimmed their price targets on Olin, reflected in a lower internal fair value estimate from $37.96 to $35.83, as they factor in softer chlor-alkali conditions, oil price moves, and added uncertainty around the Huntsman merger.

Analyst Commentary

Recent Street research around Olin highlights a wide range of views, with several firms trimming price targets while others point to potential upside if the company executes on its plans and the Huntsman merger progresses as expected. For you as an investor, the key is to separate short term caution on chemicals pricing from longer term views on Olin's portfolio mix and capital allocation.

On the cautious side, several firms have reduced their Olin price targets into the low to mid US$20s, pointing to softer chlor alkali conditions, weaker oil price support and uncertainty around the Huntsman tie up. Some of these analysts also expect commodity exposed chemical companies to strike a conservative tone around Q2 results and second half commentary.

At the same time, there are indications that not all coverage is leaning bearish. JPMorgan has kept a Neutral stance while adjusting its Olin target in a relatively tight range between US$25 and US$26 across recent reports, and bullish analysts earlier took targets into the high US$20s to low US$30s as they updated models for pricing and cost advantages. For investors tracking sentiment, that mix of caution and support helps frame where Olin sits in the broader chemicals coverage universe.

Huntsman related commentary also matters for Olin. Mizuho shifted Huntsman to Neutral, explicitly tying that rating to its Neutral view on Olin following the merger announcement. The firm highlighted Olin's gas advantaged chlorine, caustic and ethylene positions, alongside Huntsman's more differentiated downstream polyurethane and epoxy exposure, suggesting that the combined group could have a more balanced earnings profile across upstream and downstream chemicals.

Macro references in the research are mostly descriptive rather than directional. Housing and autos are flagged as softer end markets, while electronics and aerospace are cited as relatively stronger. Oil is described as having moved off prior highs, with one report linking this to reduced support for basic chemicals but a better backdrop for certain specialty and coatings exposures. For Olin, those cross currents help explain why fair value estimates are being nudged rather than completely reset.

For readers evaluating Olin stock, the message from this research set is that Street expectations sit in a middle ground. There is clear concern around growth visibility and merger execution, but there is also recognition of Olin's cost positions and the potential benefits of pairing its upstream strengths with Huntsman's downstream portfolio if integration is managed effectively.

Bullish Takeaways

  • Bullish analysts earlier took Olin targets toward the US$29 to US$31 range as they refreshed models, reflecting confidence that prior pricing and execution could support higher fair value than earlier estimates.
  • JPMorgan has kept a Neutral rating while setting Olin's target in the mid US$20s, which signals neither capitulation nor aggressive optimism and suggests that, in its work, execution and valuation still line up reasonably with current fundamentals.
  • Mizuho's decision to move Huntsman up to Neutral explicitly to match its Neutral stance on Olin underscores a view that the combined company could benefit from Olin's relative cost advantages in U.S. gas advantaged chlorine, caustic and ethylene.
  • Across earlier positive target revisions from several large firms, bullish analysts framed Olin as benefiting from pricing momentum and a more balanced portfolio, which they saw as supportive of the stock's valuation if the company continues to deliver on its plans.

What’s in the News for Olin

  • Olin and Huntsman announced that their S 4 Registration Statement for the planned merger of equals is effective. This is a step that supports plans to create a combined integrated North American chemicals company with more than US$12b in scale. [Source: company announcement]
  • Law firms Monteverde & Associates PC and Halper Sadeh LLC are reviewing the Olin Huntsman merger terms, focusing on potential federal securities law and fiduciary duty issues. This includes the planned ownership split where Olin shareholders would hold about 54.5% of the combined company and Huntsman shareholders would receive 0.5476 Olin shares for each Huntsman share. [Source: legal firm releases]
  • BofA Global Research downgraded Olin to Underperform and flagged concerns around the outlook for earnings recovery. It also noted added risks tied to the Huntsman merger, particularly in housing related markets. This was followed by a premarket share price move described as a nearly 3% decline on June 30, 2026. [Source: BofA Global Research]
  • Plug Power disclosed the sale of about US$39.2m of federal investment tax credits related to its hydrogen liquefaction facility in St. Gabriel, Louisiana, which operates as a joint venture with Olin and is described as one of North America’s largest hydrogen liquefaction plants. [Source: Plug Power news]
  • Olin reported that from January 1, 2026 to March 31, 2026, it repurchased no additional shares under existing programs. It confirmed cumulative buybacks of 27,364,471 shares for US$1,351.1m under the July 28, 2022 authorization, and it has scheduled a special or extraordinary shareholders meeting for August 25, 2026. [Source: company filings]

Valuation Changes for Olin

  • Fair Value: The internal fair value estimate for Olin has been reduced from $37.96 to $35.83, a decline of about 5.6%.
  • Discount Rate: The discount rate has moved slightly lower from 9.53% to 9.48%, a change of around 0.05 percentage points.
  • Revenue Growth: Modeled revenue growth has edged up from 7.79% to 7.86%, an increase of roughly 0.07 percentage points.
  • Net Profit Margin: The assumed net profit margin has risen from 5.98% to 6.13%, an increase of around 0.16 percentage points.
  • Future P/E: The future P/E assumption has been reduced from 11.0x to 10.1x, a decline of around 8.3% that lowers the multiple applied to Olin's earnings.
2 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic expansion in PVC, specialty epoxies, and military ammunition positions Olin to benefit from global infrastructure, electrification, and defense trends.
  • Focus on pricing power, operating flexibility, and cost reductions boosts margins, cash flow, and capacity for growth investments and shareholder returns.
  • Structural headwinds from weak demand, cost inflation, legacy assets, regulatory risk, and material substitution threaten margins, cash flow, and long-term viability of Olin's core businesses.

Catalysts

About Olin
    Manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada.
What are the underlying business or industry changes driving this perspective?
  • Olin’s entry and expansion in the PVC market through low-capital tolling arrangements positions the company to leverage accelerating global infrastructure, construction, and consumer goods demand, which could meaningfully grow revenue and incremental EBITDA as emerging markets, urbanization, and population growth drive long-term end-use consumption for its chlor-alkali and vinyl portfolio.
  • Strategic focus on higher-value specialty and formulated epoxy products suited for electric vehicles, wind turbines, and grid infrastructure enables Olin to participate directly in the booming electrification and decarbonization buildout, boosting both top-line sales and driving margin expansion in its Epoxy segment as demand shifts towards advanced chemical materials.
  • Ongoing capacity discipline across the chemical sector, combined with Olin’s “value-first” commercial approach and operating flexibility, is likely to result in improved pricing power and more stable, elevated average selling prices for caustic soda, chlorine, and derivatives, which has a direct positive impact on EBITDA and operating margins over time.
  • Robust domestic and international military ammunition demand, highlighted by new multi-year and extended government contracts as well as the accretive AMMO Inc. acquisition, creates a strong platform for sustained growth in Winchester earnings, supporting both revenue expansion and higher returns on invested capital as geopolitical tensions drive higher global defense spending.
  • Company-wide acceleration of cost reductions, automation, and productivity initiatives—outpacing original targets—position Olin to generate meaningfully higher free cash flow and EPS through improved operating leverage, supporting reinvestment in growth opportunities and potentially significant share repurchases for shareholder value creation.
Olin Earnings and Revenue Growth

Olin Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more optimistic perspective on Olin compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
  • The bullish analysts are assuming Olin's revenue will grow by 7.9% annually over the next 3 years.
  • The bullish analysts assume that profit margins will increase from -2.8% today to 6.1% in 3 years time.
  • The bullish analysts expect earnings to reach $516.9 million (and earnings per share of $4.51) by about July 2029, up from -$184.9 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $71.0 million.
  • In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 10.2x on those 2029 earnings, up from -13.4x today. This future PE is lower than the current PE for the US Chemicals industry at 25.2x.
  • The bullish analysts expect the number of shares outstanding to decline by 0.65% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.48%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Olin's core chlor-alkali and epoxy businesses face sustained earnings volatility due to cyclical demand, weak downstream markets such as construction and automotive, and persistent global overcapacity—especially in epoxy where Asian competition remains intense and recent anti-dumping efforts offer little relief, which will weigh on both revenue and net margins over the long term.
  • The company highlighted higher cost pressures from rising raw material and energy input prices, supply chain tariffs, and operational disruptions such as plant turnarounds, which could erode profitability over time and limit sustainable improvements in earnings.
  • Olin is reliant on legacy manufacturing assets that require ongoing capital expenditure for maintenance and modernization, creating pressure on free cash flow and reducing its ability to invest in growth or return capital to shareholders, which may impact long-term shareholder value.
  • Increasing environmental and regulatory scrutiny, along with the global shift towards decarbonization and stricter water usage requirements, creates a risk of significantly higher compliance costs, potential legal liabilities, and even production restrictions, all of which threaten to compress future profit margins.
  • The risk of long-term demand erosion for commodity chemicals due to customer adoption of recycled, bio-based, or alternative materials, as well as intensifying competition from lower-cost producers in Asia and the Middle East, could drive structural declines in volumes and revenue as secular trends shift against Olin’s core products.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bullish price target for Olin is $35.83, which represents up to two standard deviations above the consensus price target of $26.71. This valuation is based on what can be assumed as the expectations of Olin's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $39.0, and the most bearish reporting a price target of just $21.0.
  • In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $8.4 billion, earnings will come to $516.9 million, and it would be trading on a PE ratio of 10.2x, assuming you use a discount rate of 9.5%.
  • Given the current share price of $21.66, the analyst price target of $35.83 is 39.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Olin?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$35.83
vs US$19.0646.8% undervalued intrinsic discount
PastFuture-233m10b2015201820212024202620272029Revenue US$8.4bEarnings US$516.9m
7.9%
Revenue growth
6.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Olin

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Undervalued with moderate growth potential.

Market capUS$2.1b
PB1.3x
Estimated Growth4.3%
Dividend Yield4.2%
Full analysis

CEO & management

Kenneth Lane
CEO
5.2yrs
CEO Tenure

Manufactures and distributes chemical products in the United States, Europe, Asia Pacific, the Middle East, Africa, and India Middle East, Africa, India, Latin America, and Canada.